Cargando…
Epitope mapping of anti-drug antibodies to a clinical candidate bispecific antibody
Anti-drug antibodies (ADA) can limit the efficacy and safety of therapeutic antibodies. However, determining the exact nature of ADA interactions with the target drug via epitope mapping is challenging due to the polyclonal nature of the IgG response. Here, we demonstrate successful proof-of-concept...
Autores principales: | Schick, Arthur J., Lundin, Victor, Low, Justin, Peng, Kun, Vandlen, Richard, Wecksler, Aaron T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794239/ https://www.ncbi.nlm.nih.gov/pubmed/35072596 http://dx.doi.org/10.1080/19420862.2022.2028337 |
Ejemplares similares
-
Bioprocess Development and Characterization of a (13)C-Labeled Hybrid Bispecific Antibody Produced in Escherichia coli
por: Wecksler, Aaron T., et al.
Publicado: (2023) -
An integrated approach for characterizing immunogenic responses toward a bispecific antibody
por: Cohen, Sivan, et al.
Publicado: (2021) -
Bispecific antibodies and their applications
por: Fan, Gaowei, et al.
Publicado: (2015) -
The making of bispecific antibodies
por: Brinkmann, Ulrich, et al.
Publicado: (2017) -
Elucidation of Critical Epitope of Anti-Rat Podoplanin Monoclonal Antibody PMab-2
por: Furusawa, Yoshikazu, et al.
Publicado: (2018)